Lin, Jiin-huey Chern (Winnetka, IL, US)
Ju, Chien-ping (Carbondale, IL, US)
Tien, Yin-chun (Kaohsiung, TW)
Tsai, Chih-hung (Taichung, TW)
Ning, Chao-chin (Kaohsiung, TW)
Chao, Chung-po (Bade, TW)

Plaque It! Sponsored by: Flash of Genius

11/071631

08/01/2006

03/03/2005

Images are available in PDF form when logged in. To view PDFs, Login  or  Create Account (Free!)

View patents that cite this patent

Click for automatic bibliography generation

Calcitec, Inc. (Austin, TX, US)

264/42

264/49, 264/333

A61F2/28; B29C39/02

264/250, 264/87, 264/49, 264/42, 264/333, 264/86, 264/251

3679360		July, 1972	Rubin et al.
4371484	Process for making porous sintered body of calcium phosphate	February, 1983	Inukai et al.
4481175	Process for preparing apatite	November, 1984	Iino et al.
4518430	Dental resptorative cement pastes	May, 1985	Brown et al.
4553272	Regeneration of living tissues by growth of isolated cells in porous implant and product thereof	November, 1985	Mears
4612053	Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements	September, 1986	Brown et al.
4623553	Method of producing a bone substitute material	November, 1986	Ries et al.
RE33161	Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements	February, 1990	Brown et al.	423/308
RE33221	Dental restorative cement pastes	May, 1990	Brown et al.
4959104	Self-hardenable material	September, 1990	Iino et al.
5017518	Process for producing calcium phosphate ceramics having porous surface	May, 1991	Hirayama et al.
5053212	Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite	October, 1991	Constantz et al.
5092888	Hardening material	March, 1992	Iwamoto et al.
5149368	Resorbable bioactive calcium phosphate cement	September, 1992	Liu et al.
5152791	Prosthetic artificial bone having ceramic layers of different porosity	October, 1992	Hakamatsuka et al.
5164187	Hydroxyapatite prosthesis coatings	November, 1992	Constantz et al.
5180426	Composition for forming calcium phosphate type setting material and process for producing setting material	January, 1993	Sumita
5262166	Resorbable bioactive phosphate containing cements	November, 1993	Liu et al.
5336264	Situ prepared calcium phosphate composition and method	August, 1994	Constantz et al.
5338356	Calcium phosphate granular cement and method for producing same	August, 1994	Hirano et al.
5342441	Biologically compatible hardening material for dental or medical applications	August, 1994	Mandai et al.
5409982	Tetracalcium phosphate-based materials and process for their preparation	April, 1995	Imura et al.
5476647	Complex calcium and fluoride containing mouth rinses, dentifrices, and chewable tablets	December, 1995	Chow et al.
5492768	Porous living body repairing member, and a method of imparting elasticity to it	February, 1996	Okimatsu et al.
5496399	Storage stable calcium phosphate cements	March, 1996	Ison et al.
5503164	Device and method for repair of craniomaxillofacial bone defects including burr holes	April, 1996	Friedman
5522893	Calcium phosphate hydroxyapatite precursor and methods for making and using the same	June, 1996	Chow et al.
5525148	Self-setting calcium phosphate cements and methods for preparing and using them	June, 1996	Chow et al.
5536575	Tetracalcium phosphate-based materials and processes for their preparation	July, 1996	Imura et al.
5542973	Calcium phosphate hydroxyapatite precursor and methods for making and using the same	August, 1996	Chow et al.
5545254	Calcium phosphate hydroxyapatite precursor and methods for making and using the same	August, 1996	Chow et al.
5550172	Utilization of biocompatible adhesive/sealant materials for securing surgical devices	August, 1996	Regula et al.
5569490	Tetracalcium phosphate-based materials and processes for their preparation	October, 1996	Imura et al.
5605713	Process for the preparation of calcium phosphate cements and its application as bio-materials	February, 1997	Boltong
5607685	Protracted-release adminstration forms containing clindamycin palmitate	March, 1997	Cimbollek et al.
5652016	Tetracalcium phosphate-based materials and processes for their preparation	July, 1997	Imura et al.
5683461	Synthesis of reactive amorphous calcium phosphates	November, 1997	Lee et al.
5683496	Storage stable calcium phosphate cements	November, 1997	Ison et al.
5695729	Calcium phosphate hydroxyapatite precursor and methods for making and using the same	December, 1997	Chow et al.
5697981	Method for repairing bone	December, 1997	Ison et al.
5702449	Reinforced porous spinal implants	December, 1997	McKay
5766669	Sintering process for producing thin films of calcium phosphate entities	June, 1998	Pugh et al.
5782971	Calcium phosphate cements comprising amorophous calcium phosphate	July, 1998	Constantz et al.
5814681	Restorative composition for hard tissue and dispensing apparatus therefor	September, 1998	Hino et al.
5820632	Prepared calcium phosphate composition and method	October, 1998	Constantz et al.
5846312	Storage stable calcium phosphate cements	December, 1998	Ison et al.
5891448	Control of calcium fluoride formation in mouth rinses, dentifrices and gels	April, 1999	Chow et al.
5899939	Bone-derived implant for load-supporting applications	May, 1999	Boyce et al.
5954867	Self setting calcium phosphate cements and methods for preparing and using them	September, 1999	Chow et al.
5958430	Thin film composition with biological substance and method of making	September, 1999	Campbell et al.
5964932	Storage stable calcium phosphate cements	October, 1999	Ison et al.
5976234	Self-setting calcium phosphate cements and methods for preparing and using them	November, 1999	Chow et al.
5993535	Calcium phosphate cement and calcium phosphate cement composition	November, 1999	Sawamura et al.
5997624	Self-setting calcium phosphate cements and methods for preparing and using them	December, 1999	Chow et al.
6005162	Methods of repairing bone	December, 1999	Constantz
6013591	Nanocrystalline apatites and composites, prostheses incorporating them, and method for their production	January, 2000	Ying et al.
6013853	Continuous release polymeric implant carrier	January, 2000	Athanasiou et al.
6018095	Method for preparing an implantable composite material, resulting material, implant including said material, and kit therefor	January, 2000	Lerch et al.
6027742	Bioresorbable ceramic composites	February, 2000	Lee et al.
6077989	Resorbable implant biomaterial made of condensed calcium phosphate particles	June, 2000	Kandel et al.
6117456	Methods and products related to the physical conversion of reactive amorphous calcium phosphate	September, 2000	Lee et al.
6118043	Bone replacement material with FGF	September, 2000	Nies et al.
6123731	Osteoimplant and method for its manufacture	September, 2000	Boyce et al.
6132463	Cell seeding of ceramic compositions	October, 2000	Lee et al.
6149688	Artificial bone graft implant	November, 2000	Brosnahan et al.
6162258	Lyophilized monolithic bone implant and method for treating bone	December, 2000	Scarborough et al.
6277149	Ramp-shaped intervertebral implant	August, 2001	Boyle et al.
6294041	Method for an osteoimplant manufacture	September, 2001	Boyce et al.
6294187	Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same	September, 2001	Boyce et al.
6323146	Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity	November, 2001	Pugh et al.
6325987	Minerals and methods for their production and use	December, 2001	Sapieszko et al.
6325992	Calcium phosphate hydroxyapatite precursor and methods for making and using the same	December, 2001	Chow et al.
6332779	Method of hard tissue repair	December, 2001	Boyce et al.
6340648	Calcium phosphate porous sintered body and production thereof	January, 2002	Imura et al.
6379453	Process for producing fast-setting, bioresorbable calcium phosphate cements	April, 2002	Lin et al.
6440444	Load bearing osteoimplant and method of repairing bone using the same	August, 2002	Boyce et al.
6458162	Composite shaped bodies and methods for their production and use	October, 2002	Koblish et al.
6478825	Implant, method of making same and use of the implant for the treatment of bone defects	November, 2002	Winterbottom et al.
6495156	Biocements having improved compressive strength	December, 2002	Wenz et al.
6530955	Ramp-shaped intervertebral implant	March, 2003	Boyle et al.
6547866	Porous calcium phosphate cement	April, 2003	Edwards et al.
6569489	Bioactive ceramic coating and method	May, 2003	Li
6585992	Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity	July, 2003	Pugh et al.
6616742	Process for preparing a paste from calcium phosphate cement	September, 2003	Lin et al.
6648960	Method of shortening a working and setting time of a calcium phosphate cement (CPC) paste	November, 2003	Lin et al.
6670293	Porous calcium phosphate cement	December, 2003	Edwards et al.
6696073	Shaped load-bearing osteoimplant and methods of making same	February, 2004	Boyce et al.
6719989	Sustained release drug carrier, and method of manufacturing sustained release drug carrier	April, 2004	Matsushima et al.
6752831	Biocompatible osteogenic band for repair of spinal disorders	June, 2004	Sybert et al.
6793725	Premixed calcium phosphate cement pastes	September, 2004	Chow et al.
6808561	Biocompatible cement containing reactive calcium phosphate nanoparticles and methods for making and using such cement	October, 2004	Genge et al.
6808585	Osteogenic implants derived from bone	October, 2004	Boyce et al.
6840995	Process for producing fast-setting, bioresorbable calcium phosphate cements	January, 2005	Lin et al.
6929692	Calcium phosphate cement composition and a method for the preparation thereof	August, 2005	Tas
6953594	Method of preparing a poorly crystalline calcium phosphate and methods of its use	October, 2005	Lee et al.
6955716	Self-hardening calcium phosphate materials with high resistance to fracture, controlled strength histories and tailored macropore formation rates	October, 2005	Xu et al.
6960249	Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface	November, 2005	Lin et al.
20020019635	Method for fixing a graft in a bone tunnel	February, 2002	Wenstrom, Jr. et al.
20020073894	Biocompatible cement containing reactive calcium phosphate nanoparticles and methods for making and using such cement	June, 2002	Genge et al.
20020137812	Premixed calcium phosphate cement pastes	September, 2002	Chow et al.
20020169066	Dense porous structures for use as bone substitutes	November, 2002	Cassidy et al.
20030019396	Porous calcium phosphate cement	January, 2003	Edwards et al.
20030021824	Method for preparing a calcium phosphate pasty material for injection	January, 2003	Lacout et al.	424/423
20030031698	Composite biomaterial including anisometric calcium phosphate reinforcement particles and related methods	February, 2003	Roeder et al.
20030039676	Shaped load-bearing osteoimplant and methods of making same	February, 2003	Boyce et al.
20030055512	Calcium based neutral and bioresorbable bone graft	March, 2003	Genin et al.
20030074081	Non-uniform porosity tissue implant	April, 2003	Ayers et al.
20030078317	Process for preparing a paste from calcium phosphate cement	April, 2003	Lin et al.
20030120351	Synthesis of calcium phosphates by mechano-chemical process	June, 2003	Tofighi
20030121450	Process for producing fast-setting, bioresorbable calcium phosphate cements	July, 2003	Lin et al.
20030167093	Self-hardening calcium phosphate materials with high resistance to fracture, controlled strength histories and tailored macropore formation rates	September, 2003	Xu et al.
20030216777	Method of enhancing healing of interfacial gap between bone and tendon or ligament	November, 2003	Tien et al.
20040003757	Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface	January, 2004	Chern Lin et al.
20040022825	Calcium phosphate bone replacement materials and methods of use thereof	February, 2004	Lagow
20040031420	Calcium phosphate cement, use and preparation thereof	February, 2004	Lin et al.
20040076685	Method of preparing porous calcium phosphate morsels and granules via gelatin processing	April, 2004	Tas
20040137032	Combinations of calcium phosphates, bone growth factors, and pore-forming additives as osteoconductive and osteoinductive composite bone grafts	July, 2004	Wang
20040175320	Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface and process for preparing the same	September, 2004	Lin et al.
20040180091	Carbonated hydroxyapatite-based microspherical composites for biomedical uses	September, 2004	Lin
20040185181	Porous sintered body of calcium phosphate-based ceramic and method for producing same	September, 2004	Matsumoto
20040186481	Method for forming a hardened cement in a bone cavity	September, 2004	Chern Lin et al.
20050008759	Grain protein-based formulations and methods of using same	January, 2005	Nie et al.
20050076813	Process for producing fast-setting, bioresorbable calcium phosphate cements	April, 2005	Lin et al.
20050101964	Spinal fusion procedure using an injectable bone substitute	May, 2005	Lin et al.
20050184417	METHOD FOR MAKING A POROUS CALCIUM PHOSPHATE ARTICLE	August, 2005	Chern Lin et al.
20050186353	Method for making a porous calcium phosphate article	August, 2005	Lin et al.
20050186354	Method for making a porous calcium phosphate article	August, 2005	Lin et al.
20050186449	Method for making a porous calcium phosphate article	August, 2005	Lin et al.
20050263919	Dual function prosthetic bone implant and method for preparing the same	December, 2005	Lin et al.
20050263920	Dual function prosthetic bone implant and method for preparing the same	December, 2005	Lin et al.
20050263922	Dual function prosthetic bone implant and method for preparing the same	December, 2005	Lin et al.
20050263927	Dual function prosthetic bone implant and method for preparing the same	December, 2005	Lin et al.
20050263928	Dual function prosthetic bone implant and method for preparing the same	December, 2005	Lin et al.
20050263929	Dual function prosthetic bone implant and method for preparing the same	December, 2005	Lin et al.
20050263930	Dual function prosthetic bone implant and method for preparing the same	December, 2005	Lin et al.
20050263931	Dual function prosthetic bone implant and method for preparing the same	December, 2005	Lin et al.
20050267587	Dual function prosthetic bone implant and method for preparing the same	December, 2005	Lin et al.
20050267588	Dual function prosthetic bone implant and method for preparing the same	December, 2005	Lin et al.
20050267589	Dual function prosthetic bone implant and method for preparing the same	December, 2005	Lin et al.
20050267592	DUAL FUNCTION PROSTHETIC BONE IMPLANT AND METHOD FOR PREPARING THE SAME	December, 2005	Lin et al.
20050267593	Dual function prosthetic bone implant and method for preparing the same	December, 2005	Lin et al.
20050267604	Dual function prosthetic bone implant and method for preparing the same	December, 2005	Lin et al.

EP0267624	May, 1988			Porous calcium phosphate based bone prosthesis.
JP06228011	August, 1994
WO/2003/055418	July, 2003			CALCIUM PHOSPHATE BONE REPLACEMENT MATERIALS AND METHODS OF USE THEREOF

PCT/US04/11637 Inetrnational Search Report/Written Opinion, Oct. 2004, Examiner Koslow.
PCT/US04/11637 International Search Report/Written Opinion, mailed Mar. 11, 2005, Examiner Boehm.
Sugawara et al., “Calcium Phosphate Cement: An In Vitro Study of Dentin Hypersensitivity Using Calcium Phosphate Cement”, The Journal of the Japanese Society for Dental Materials and Devices, 1989, vol. 8, pp. 282-294.
Pickel et al., “The Effects of a Chewing Gum Containing Dicalcium Phosphate on Salivary Calcium and Phosphate”, Ala. J. Med. Sci., 1965, vol. 2, pp. 286-287.
Matsuya et al., “Effects of pH on the Reactions of Tetracalcium Phosphate and Dicalcium Phosphate”, IADR Abstract, Apr. 1991.
Sugawara et al., “Formation of Hydroxyapatite in Hydrogels from Tetracalcium Phosphate/Dicalcium Phosphate Mixtures,” J. Nihon. Univ. Sch. Dent., 1989, vol. 31, pp. 372-381.
Hong et al., “The Periapical Tissue Reactions to a Calcium Phosphate Cement in the Teeth of Monkeys,” J. Biomed. Mater. Res., Apr. 1991, vol. 25(4), pp. 485-498.
de Rijk, et al., “Clinical Evaluation of a Hydroxyapatite Precipitate for the Treatment of Dentinal Hypersensitivity,” Biomedical Engineering v. Recent Developments, Proc. of 5th Southern Biomedical Engineering Conference, 1986, pp. 336-339. (Pergamon Press, New York).
Gruninger et al., “Evaluation of the Biocompatibility of a New Calcium Phosphate Setting Cement,” J. Dent. Res., 1984, 63, Abst. No. 270 (4 pages).
Costantino et al., “Evaluation of a New Hydroxyapatite Cement: Part III: Cranioplasty in a Cat Model,” The Fifth Intl. Symposium on Facial Plastic Reconstructive Surgery of the Head and Neck, Toronto, Canada, 1989. (18 pages).
Shindo, et al., “Facial Skeletal Augmentation Using Hydroxyapatite Cement,” Arch. Otolaryngol. Head Neck Surg., 1993, vol. 119, pp. 185-190.
Briner et al., “Significance of Enamel Remineralization”, J. Dent. Res., 1974, vol. 53, pp. 239-243.
Silverstone L.M., “Remineralization Phenomena”, Caries Res., 1977, vol. 11 (Supp. 1), pp. 59-84.
Costantino et al., “Hydroxyapatite Cement: I. Basic Chemistry and Histologic Properties,” Arch. Otolaryngol. Head Neck Surg., 1991, vol. 117, pp. 379-394.
Friedman et al., “Hydroxyapatite Cement: II. Obliteration and Reconstruction of the Cat Frontal Sinus,” Arch. Otolary. Head Neck Surg., 1991, vol. 117, pp. 385-389.
Costantino et al., “Experimental Hydroxyapatite Cement Cranioplasty,” Plast. Reconstr. Surg., 1992, vol. 90, No. 2, pp. 174-185.
Miyazaki et al., “An Infrared Spectroscopic Study of Cement Formation of Polymeric Calcium Phosphate Cement,” The Journal of the Japanese Society for Dental Materials and Devices, 1992, vol. 11, No. 2, pp. 278-284.
Driskell et al., “Development of Ceramic and Ceramic Composite Devices for Maxillofacial Applications”, J. Biomed. Mater. Res. Symposium, 1972, vol. 6, No. 2 (part 2), pp. 345-361.
Hiatt et al., “Root Preparation I. Obturation of Dentinal Tubules in Treatment of Root Hypersensitivity”, J. Periodontal., 1972, vol. 41, No. 6, pp. 373-380.
Patel et al., “Solubility of CaHPO4·2H2O in the Quaternary System Ca(OH)2-H3PO4-NaCl-H2O at 25° C.,” J. Res. Nat. Bur. Stand. (Physics Chem.), 1974, vol. 78A, pp. 675-681.
Salyer et al., “Porous Hydroxyapatite as an Onlay Bone-Graft Substitute for Maxillofacial Surgery,” Presented at the 54th Annual Scientific Meeting of the American Society of Plastic and Reconstructive Surgeons, Kansas City, Missouri, 1985, pp. 236-244.
Kenney et al., “The Use of a Porous Hydroxylapatite Implant in Periodontal Defects: II. Treatment of Class II Furcation Lesions in Lower Mōlars,” J. Periodontal, 1988, pp. 67-72.
Zide et al., “Hydroxylapatite Cranioplasty Directly Over Dura,” J. Oral Maxillofac. Surg., 1987, vol. 45, pp. 481-486.
Waite et al., “Zygomatic Augmentation with Hydroxylapatite: A Preliminary Report,” J. Oral Maxillofac. Surg., 1986, pp. 349-352.
Verwoerd, et al. Porous Hydroxylapatite-perichondrium Graft in Cricoid Reconstruction, Acta Otolaryngol., 1987, vol. 103, pp. 496-502.
Grote, “Tympanoplasty With Calcium Phosphate,” Arch. Otolaryngol., 1984, vol. 110, pp. 197-199.
Kent et al., “Alveolar Ridge Augmentation Using Nonresorbable Hydroxylapatite with or without Autogenous Cancellous Bone,” J. Oral Maxillofac. Surg., 1983, vol. 41, pp. 629-642.
Piecuch, J.F., “Augmentation of the Atrophic Edentulous Ridge with Porous Replamineform Hydroxyapatite (Interpore-200)”, Dental Clinics of North America, 1986, vol. 30(2), pp. 291-305.
Misch, C.E., “Maxillary Sinus Augmentation for Endosteal Implants: Organized Alternative Treatment Plans,” Int. J. Oral. Implant., 1987, vol. 4(2), pp. 49-58.
Chohayeb, et al., “Evaluation of Calcium Phosphate as a Root Canal Sealer-Filler Material,” J. Endod., 1987, vol. 13, pp. 384-386.
Brown et al., “Crystallography of Tetracalcium Phosphate,” J. Res. Nat. Bur. Stand. (Physics Chem.), 1965, vol. 69A, pp. 547-551.
Sanin et al., “Particle Size Effects on pH and Strength of Calcium Phosphate Cement,” IADR Abstract, Apr. 1991.
Chow et al., “X-ray Diffraction and Electron Microscopic Characterization of Calcium Phosphate Cement Setting Reactions,” IADR Abstract, 1987.
Block et al. “Correction of Vertical Orbital Dystopia with a Hydroxylapatite Orbital Floor Graft,” J. Oral Maxillofac. Surg., 1988, vol. 46, pp. 420-425.
Brown, W.E., “Solubilities of Phosphates and Other Sparingly Soluble Compounds”, Environmental Phosphorous Handbook, 1973, pp. 203-239. (John Wiley & Sons, New York).
Gregory et al., “Solubility of CaHPO4·2H2O in the System Ca(OH)2-H3PO4-H2O at 5, 15, 25, and 37.5° C.,” J. Res. Nat. Bur. Stand. (Physics Chem.), 1970, vol. 74A, No. 4, pp. 461-475.
Gregory et al., “Solubility of β-Ca3(PO4)2 in the System Ca(OH)2 -H3PO4-H2O at 5, 15, 25 and 37° C.,” J. Res. Nat. Bur. Stand. (Physics Chem.), 1974, vol. 78A, No. 6, pp. 667-674.
McDowell et al., “Solubility of Ca5(PO4)3OH in the System Ca(OH)2-H3PO4-H2O at 5, 15, 25 and 37° C.,” J. Res. Nat. Bur. Stand. (Physics Chem.), 1977, vol. 91A, Nos. 2 and 3, pp. 273-281.
McDowell et al., “Solubility Study of Calcium Hydrogen Phosphate. Ion Pair Formation,” Inorg. Chem., 1971, vol. 10, pp. 1638-1643.
Moreno et al., “Stability of Dicalcium Phosphate Dyhydrate in Aqueous Solutions and Solubility of Octocalcium Phosphate,” Proc. Soil Sci. Soc. Am., 1960, vol. 21, pp. 99-102.
Chow et al, “Self-Setting Calcium Phosphate Cements,” Mat. Res. Soc. Symp. Proc., vol. 179, 1991, pp. 3-23.
Miyazaki et al., “Chemical Change of Hardened PCA/CPC Cements in Various Storing Solutions”, The Journal of the Japanese Society for Dental Materials and Devices, 1992, vol. 11, No. 2, pp. 324-330.
Fukase et al, “Thermal Conductivity of Calcium Phosphate Cement”, IADR Abstract, Mar. 1990.
Sugawara et al., “Biocompatibility and Osteoconductivity of Calcium Phosphate Cement”, IADR Abstract, Mar. 1990.
Miyazaki et al., “Polymeric Calcium Phosphate Cements”, IADR Abstract, Mar. 1990.
Link et al., “Composite of Calcium Phosphate Cement and Genetically Engineered Protein Bioadhesive,” IADR Abstract, Mar. 1991.
Briner et al., “Significance of Enamel Remineralization”, J. Dent. Res., 1974, vol. 53, pp. 239-243.
Chow, “Development of Self-Setting Calcium Phosphate Cements”, Journal of The Ceramic Society of Japan, 1991, vol. 99 [10], pp. 954-964.
Brown et al., A New Calcium Phosphate, Water Setting Cement, Cements Research Progress 1986, P.W. Brown, Ed., Westerville, Ohio: American Ceramic Society, 1988, pp. 352-379.
Sugawara et al., “A Calcium Phosphate Root Canal Sealer-Filler” IADR Abstract, 1987.
Sugawara et al., “In Vitro Evaluation of the Sealing Ability of a Calcium Phosphate Cement When Used as a Root Canal Sealer-Filler,” J. Endodon., 1990, vol. 16, No. 4, pp. 162-165.
Chow, L.C., “Calcium Phosphate Materials: Reactor Response,” Adv. Dent. Res., 1988, vol. 2(1), pp. 181-184.
Fukase et al., “Setting Reactions and Compressive Strengths of Calcium Phosphate Cements”, J. Dent. Res., 1990, vol. 69(12), pp. 1852-1856.
Miyazaki et al., “Cements,” Guide to Dental Materials and Devices, 7th Edition, 1974-1975, Chapter 6.
Sugawara et al., “Formation of Hydroxyapatite in Hydrogels from Tetracalcium Phosphate/Dicalcium Phosphate Mixtures,” J. Nihon Univ. Sch. Dent., vol. 31, 372-381, 1989.
Chow et al. “A Natural Bone Cement-A Laboratory Novelty Led to the Development of Revolutionary New Biomaterials”, J. Res. Natl. Inst. Stand. Technol., 2001, vol. 106, pp. 1029-1033.
Gburek et al., “Mechanical Activation of Tetracalcium Phsophate,” J. Am. Ceramics Soc., vol. 87(2), pp. 311-313.

Thiesen, Mary Lynn F.

Meyertons, Hood, Kivlin, Kowert & Goetzel, P.C.
Meyertons, Eric B.

PRIORITY CLAIM

This application is a continuation of and claims the benefit of priority under 35 U.S.C. § 120 to co-pending U.S. patent application Ser. No. 10/780,728 entitled “METHOD FOR MAKING A POROUS CALCIUM PHOSPHATE ARTICLE” filed on Feb. 19, 2004, herein incorporated by reference.

What is claimed is:

1. A method of forming a porous calcium phosphate article comprising: adding a paste to a mold, wherein the paste comprises at least one calcium phosphate compound combined with at least one pore forming powder and at least one setting liquid; forming a hardened calcium phosphate article from the paste; immersing the hardened calcium phosphate article in one or more immersing liquids to form a porous calcium phosphate article; removing the resulting porous calcium phosphate article from the one or more impregnating liquids; and subjecting the removed porous calcium phosphate article to one or more heat treatments, wherein the temperature of the heat treatments is from about 50° C. to about 500° C.

2. The method of claim 1, wherein the calcium phosphate compound is selected from the group consisting of alpha-tricalcium phosphate (α-TCP), beta-tricalcium phosphate (β-TCP), tetracalcium phosphate (TTCP), monocalcium phosphate monohydrate (MCPM), monocalcium phosphate anhydrous (MCPA), dicalcium phosphate dihydrate (DCPD), dicalcium phosphate anhydrous (DCPA), octacalcium phosphate (OCP), calcium dihydrogen phosphate, calcium dihydrogen phosphate hydrate, acid calcium pyrophosphate, anhydrous calcium hydrogen phosphate, calcium hydrogen phosphate hydrate, calcium pyrophosphate, calcium triphosphate, calcium phosphate tribasic, calcium polyphosphate, calcium metaphosphate, anhydrous tricalcium phosphate, tricalcium phosphate hydrate, and amorphous calcium phosphate.

3. The method of claim 1, wherein the calcium phosphate compound comprises at least one calcium phosphate particulate compound having calcium phosphate whiskers on the surface of the particles, wherein said calcium phosphate whiskers have a length of about 1–5000 nm and a width of about 1–500 nm.

4. The method of claim 1, wherein the pore forming powder is at least partially water-soluble.

5. The method of claim 1, wherein the pore forming powder comprises an inorganic salt.

6. The method of claim 1, wherein the pore forming powder comprises an organic salt.

7. The method of claim 1, wherein the pore forming powder is selected from the list consisting of LiCl, KCl, NaCl, MgCl₂, CaCl₂, NaIO₃, KI, Na₃PO₄, K₃PO₄, Na₂CO₃, amino acid-sodium salt, amino acid-potassium salt, glucose, polysaccharide, fatty acid-sodium salt, fatty acid-potassium salt, potassium bitartrate (KHC₄H₄O₆), potassium carbonate, potassium gluconate (KC₆H₁₁O₇), potassium-sodium tartrate (KNaC₄H₄O₆.4H₂O), potassium sulfate (K₂SO₄), sodium sulfate, and sodium lactate.

8. The method of claim 1, wherein the weight ratio of pore forming powder-to-calcium phosphate cement is from about to 0.25 to about 3.0.

9. The method of claim 1, wherein the setting agent comprises an acidic solution, a basic solution, or substantially pure water.

10. The method of claim 9, wherein said acidic solution is selected from the group consisting of nitric acid (HNO₃), hydrochloric acid (HCl), phosphoric acid (H₃PO₄), carbonic acid (H₂CO₃), sodium dihydrogen phosphate (NaH₂PO₄), sodium dihydrogen phosphate monohydrate (NaH₂PO₄.H₂O), sodium dihydrogen phosphate dihydrate, sodium dihydrogen phosphate dehydrate, potassium dihydrogen phosphate (KH₂PO₄), ammonium dihydrogen phosphate (NH₄H₂PO₄), malic acid, acetic acid, lactic acid, citric acid, malonic acid, succinic acid, glutaric acid, tartaric acid, oxalic acid and mixtures thereof.

11. The method of claim 9, wherein said basic solution is selected from the group consisting of ammonia, ammonium hydroxide, alkali metal hydroxide, alkali earth hydroxide, disodium hydrogen phosphate (Na₂HPO₄), disodium hydrogen phosphate dodecahydrate, disodium hydrogen phosphate heptahydrate, sodium phosphate dodecahydrate (Na₃PO₄.12H₂O), dipotassium hydrogen phosphate (K₂HPO₄), potassium hydrogen phosphate trihydrate (K₂HPO₄.3H₂O), potassium phosphate tribasic (K₃PO₄), diammonium hydrogen phosphate ((NH₄)₂HPO₄), ammonium phosphate trihydrate ((NH₄)₃PO₄.3H₂O), sodium hydrogen carbonate (NaHCO₃), sodium carbonate Na₂CO₃, and mixtures thereof.

12. The method of claim 1, further comprising subjecting the paste to a molding pressure of greater than 1 MPa.

13. The method of claim 1, further comprising reducing the liquid-to-powder ratio of the paste by removing at least a portion of liquid from the paste.

14. The method of claim 1, wherein the article is adapted for use as a medical implant.

15. The method of claim 1, wherein the one or more liquids comprises a basic solution, an acidic solution, a solution of substantially physiological pH, an organic solvent, or substantially pure water.

16. The method of claim 1, wherein at least one of the liquids comprises at least one of a solution of HCl, a solution of (NH₄)₂HPO₄, or Hank's solution.

17. The method of claim 1, wherein the immersion liquid comprises at least one source of calcium and at least one source of phosphate.

18. The method of claim 1, wherein the hardened calcium phosphate article is immersed in one or more liquids for a period of time sufficient to remove at least a portion of the pore forming powder from the calcium phosphate article.

19. The method of claim 1, wherein the hardened calcium phosphate article is immersed in at least one immersing liquid for at least 24 hours.

20. The method of claim 1, wherein the paste further comprises living cells.

21. The method of claim 1, wherein the immersing liquid further comprises living cells.

BACKGROUND OF THE INVENTION

1. Field of the Invention

The present invention is related to a porous calcium phosphate article for use as a medical implant, and in particular to a method of making a porous calcium phosphate scaffold for use as tissue-engineered scaffold.

2. Description of the Related Art

A tissue-engineered scaffold (majority made from biodegradable polymers) has a very porous structure that allows living cells (usually taken from the patient being treated) to penetrate into the structure and be “seeded” in-vitro during a cell culture process. After a period of time (days or weeks) of cell culture, the cell-seeded scaffold is implanted into either an animal (e.g., rat) whose immune system has been removed, or into the patient himself (usually under the skin for easier later-on process). During this period of time (weeks to months) the cells quickly multiply from absorbing nutrients from the animal or the patient's body, and, at the same time, the scaffold itself is gradually dissolved or resorbed. When this process is substantially “mature”, the implant (now a real bone) is removed from under the skin of the animal or the patient and re-implanted into the (wounded or diseased) site being treated. The following are some references describing some details about the background, requirements, applications, etc. of tissue-engineered scaffold: U.S. Pat. Nos. 6,139,578; 6,200,606; 5,306,303; and 6,132,463.

It is advantageous if a tissue-engineered scaffold is bioresorbable, sufficiently porous and supportive at the same time. The conventional high temperature (usually >1000° C.)-sintered porous hydroxyapatite (HA) block material does not possess sufficient micro/nano-sized porosity and is hardly bioresorbable. On the other hand, the conventional biodegradable polymer for scaffold application exhibits a relatively low strength and too high a dissolution rate.

SUMMARY OF THE INVENTION

A primary objective of the invention is to provide a porous calcium phosphate article or block for use as a tissue-engineered scaffold, which is free from the aforesaid drawbacks in the prior art, or as a functional implant other than the tissue-engineered scaffold.

This objective is accomplished by providing a novel method for making a porous calcium phosphate article, which involves a) preparing a shaped article from a paste comprising a calcium phosphate cement, a pore-forming powder and a setting liquid; and b) immersing said shaped article in an immersing liquid for a period of time so that said pore-forming powder is dissolved in the immersing liquid, creating pores in said shaped article.

Features and advantages of the present invention are as follows:

• • 1. The porous calcium phosphate article made according to the present invention can transform into an apatite-dominated material shortly after immersion in physiological solution or after implantation.
  • 2. The porous calcium phosphate block made according to the present invention exhibits a higher strength than most other bioactive or biodegradable porous blocks with a similar porosity level.
  • 3. The calcium phosphate block made according to the present invention possesses a significant amount of micro- and nano-sized porosity, that improves bioresorbability thereof.

DETAILED DESCRIPTION OF THE INVENTION

The preferred embodiments of the present invention include (but not limited thereto):

1. A method for making a porous calcium phosphate article comprising:

• • i) preparing a shaped article from a paste comprising a calcium phosphate cement, a pore-forming powder and a setting liquid;
  • ii) ii) immersing said shaped article in an immersing liquid for a first period of time so that said pore-forming powder is dissolved in the immersing liquid, creating pores in said shaped article;
  • iii) removing the resulting porous shaped article from said immersing liquid; and
  • iv) immersing the porous shaped article from step iii) in an impregnating liquid for a second period of time so that a compressive strength of the resulting article removed from the impregnating liquid is increased compared to that of said porous shaped article without said impregnating treatment,
  • v) wherein step iii) is omitted and a compressive strength of the resulting porous shaped article removed from the immersing liquid after the first and the second periods of time is increased compared to that of the resulting porous shaped article removed after the first period of time, when the immersing liquid and the impregnating liquid are the same.

2. The method according to item 1, wherein said pore-forming powder is selected from the group consisting of LiCl, KCl, NaCl, MgCl₂, CaCl₂, NaIO₃, KINa₃, PO₄, K₃PO₄, Na₂CO₃, amino acid-sodium salt, amino acid-potassium salt, glucose, polysaccharide, fatty acid-sodium salt, fatty acid-potassium salt, potassium bitartrate (KHC₄H₄O₆), potassium carbonate, potassium gluconate (KC₆H₁₁O₇), potassium-sodium tartrate (KNaC₄H₄O₆.4H₂O) , potassium sulfate (K₂SO₄), sodium sulfate, and sodium lactate.

3. The method according to item 1, wherein the immersing liquid is an acidic aqueous solution, a basic aqueous solution, a physiological solution, an organic solvent, or a substantially pure water.

3. The method according to item 3, wherein the immersing liquid comprises at least one of Ca and P sources.

5. The method according to item 3, wherein the immersing liquid is a Hanks' solution, a HCl aqueous solution or an aqueous solution of (NH₄)₂HPO₄.

6. The method according to item 3, wherein the immersing liquid and the impregnating liquid are the same.

7. The method according to item 4, wherein the immersing liquid and the impregnating liquid are the same.

8. The method according to item 5, wherein the immersing liquid and the impregnating liquid are the same.

9. The method according to item 1, wherein the immersing liquid and the impregnating liquid are different.

10. The method according to item 9, wherein the impregnating liquid is an acidic solution, a basic solution, a physiological solution, or a substantially pure water.

11. The method according to item 10, wherein the impregnating liquid comprises at least one of Ca and P sources.

12. The method according to item 10, wherein the impregnating liquid is a Hanks' solution, a HCl aqueous solution or an aqueous solution of (NH₄)₂HPO₄.

13. The method according to item 1, wherein the first period of time is longer than 10 minutes.

14. The method according to item 13, wherein the first period of time is longer than 1 day.

15. The method according to item 1, wherein the second period of time is longer than 10 minutes.

16. The method according to item 15, wherein the second period of time is longer than 1 day.

17. The method according to item 1, wherein the immersing in step ii) and iv) is carried out at room temperature or at a temperature between about 30 and 90° C.

18. The method according to item 1, wherein said preparing of step i) comprises the following steps:

(a) preparing a first powder as said calcium phosphate cement comprising at least one Ca source and at least one P source, or at least one calcium phosphate source;

(b) mixing said first powder and the pore-forming powder with said setting liquid to form said paste, wherein said first powder and said setting liquid undergo a hardening reaction;

(c) molding said paste into an article in a mold of a desired shape and size before said hardening reaction is complete; and

(d) removing said molded article from said mold.

19. The method according to item 18, wherein said calcium phosphate source in step (a) comprises one or more calcium phosphates selected from the group consisting of alpha-tricalcium phosphate (α-TCP), beta-tricalcium phosphate (β-TCP), tetracalcium phosphate (TTCP), monocalcium phosphate monohydrate (MCPM), monocalcium phosphate anhydrous (MCPA), dicalcium phosphate dihydrate (DCPD), dicalcium phosphate anhydrous (DCPA), octacalcium phosphate (OCP), calcium dihydrogen phosphate, calcium dihydrogen phosphate hydrate, acid calcium pyrophosphate, anhydrous calcium hydrogen phosphate, calcium hydrogen phosphate hydrate, calcium pyrophosphate, calcium triphosphate, calcium phosphate tribasic, calcium polyphosphate, calcium metaphosphate, anhydrous tricalcium phosphate, tricalcium phosphate hydrate, and amorphous calcium phosphate.

20. The method according to item 19, wherein said calcium phosphate source in step (a) is tetracalcium phosphate (TTCP).

21. The method according to item 19, wherein the calcium phosphate source comprises at least one calcium phosphate particle having calcium phosphate whiskers on the surface of said calcium phosphate particle, wherein said calcium phosphate whiskers have a length of about 1–5000 nm and a width of about 1–500 nm.

22. The method according to item 19, wherein the setting liquid in step (b) is an acidic solution, a basic solution, or substantially pure water.

23. The method according to item 22, wherein said acidic solution is selected from the group consisting of nitric acid (HNO₃), hydrochloric acid (HCl), phosphoric acid (H₃PO₄), carbonic acid (H₂CO₃), sodium dihydrogen phosphate (NaH₂PO₄), sodium dihydrogen phosphate monohydrate (NaH₂PO₄.H₂O), sodium dihydrogen phosphate dihydrate, sodium dihydrogen phosphate dehydrate, potassium dihydrogen phosphate (KH₂PO₄), ammonium dihydrogen.phosphate (NH₄H₂PO₄), malic acid, acetic acid, lactic acid, citric acid, malonic acid, succinic acid, glutaric acid, tartaric acid, oxalic acid and their mixture.

24. The method according to item 22, wherein said basic solution is selected from the group consisting of ammonia, ammonium hydroxide, alkali metal hydroxide, alkali earth hydroxide, disodium hydrogen phosphate (Na₂HPO₄), disodium hydrogen phosphate dodecahydrate, disodium hydrogen phosphate heptahydrate, sodium phosphate dodecahydrate (Na₃PO₄.12H₂O), dipotassium hydrogen phosphate (K₂HPO₄), potassium hydrogen phosphate trihydrate (K₂HPO₄.3H₂O), potassium phosphate tribasic (K₃PO₄), diammonium hydrogen phosphate ((NH₄)₂HPO₄), ammonium phosphate trihydrate ((NH₄)₃PO₄.3H₂O) , sodium hydrogen carbonate (NaHCO₃), sodium carbonate Na₂CO₃, and their mixture.

25. The method according to item 18, wherein step (c) further comprises removing a portion of liquid from said paste, so that a liquid/powder ratio of said paste decreases.

26. The method according to item 18, wherein step (c) further comprises pressurizing said paste in said mold before said hardening reaction is complete to remove a portion of liquid from said paste, so that a liquid/powder ratio of said paste decreases.

27. The method according to item 26, wherein said pressuring is about 1 to 500 MPa.

28. The method according to item 26, wherein step (c) further comprises heating said paste during said pressurizing.

29. The method according to item 18, wherein step (c) further comprises heating said paste during molding.

30. The method according to item 1 further comprising removing the resulting porous shaped article having an increased compressive strength from said impregnating liquid; and cleaning and drying said porous shaped article after removed from said impregnating liquid.

31. The method according to item 30 further comprising heating the resulting cleaned and dried porous shaped article.

32. The method according to item 31, wherein said heating is conducted at a temperature between 50 and 500° C.

33. The method according to item 1, wherein said paste in step i) further comprises living cells.

34. The method according to item 1, wherein said immersing liquid in step ii) comprises living cells.

35. The method according to item 1, wherein said impregnating liquid in step iv) comprises living cells.

36. The method according to item 1, wherein said porous shaped article having an increased compressive strength removed from said impregnating liquid in step iv) has a porosity of at least 30 vol %.

37. The method according to item 1, wherein said porous shaped article having an increased compressive strength removed from said impregnating liquid in step iv) has a porosity of 50–90 vol %.

The porous shaped calcium phosphate article made according to the method of the present invention may be used as a tissue-engineered scaffold, medical implant or a reinforcing constituent of a composite.

The following examples are intended to demonstrate the invention more fully without acting as a limitation upon its scope, since numerous modifications and variations will be apparent to those skilled in this art.

PREPARATIVE EXAMPLE 1

Preparation of TTCP Powder

A Ca₄(PO₄)₂O (TTCP) powder was prepared by mixing Ca₂P₂O₇ powder with CaCO₃ powder uniformly in ethanol for 24 hours followed by heating to dry. The mixing ratio of Ca₂P₂O₇ powder to CaCO₃ powder was 1:1.27 (weight ratio) and the powder mixture was heated to 1400° C. to allow two powders to react to form TTCP.

PREPARATIVE EXAMPLE 2

Preparation of Non-Dispersive TTCP/DCPA-Based CPC Powder (Abbreviated as ND-CPC)

The TTCP powder prepared according to the method of PREPARATIVE EXAMPLE 1 was sieved and blended with dried CaHPO₄ (DCPA) powder in a ball mill for 12 hours. The blending ratio of the TTCP powder to the DCPA powder was 1:1 (molar ratio). The resultant powder mixture was added to a 25 mM diluted solution of phosphate to obtain a powder/solution mixture having a concentration of 3 g powder mixture per 1 ml solution while stirring. The resulting powder/solution mixture was formed into pellets, and the pellets were heated in an oven at 50° C. for 10 minutes. The pellets were then uniformly ground in a mechanical mill for 20 minutes to obtain the non-dispersive TTCP/DCPA-based CPC powder (ND-CPC). The particles of this ND-CPC powder have whiskers on the surfaces thereof.

EXAMPLE 1

Effect of KCl Content and Immersion Time on Compressive Strength of Porous CPC Block

To a setting solution of 1 M phosphoric acid solution (pH=5.89) the ND-CPC powder from PREPARATIVE EXAMPLE 2 was added in a liquid/powder ratio (L/P ratio) of 0.4, i.e. 4 ml liquid/10 g powder, while stirring. KCl powder in a predetermined amount was mixed to the resulting mixture by stirring intensively. The resulting paste was filled into a cylindrical steel mold having a length of 12 mm and a diameter of 6 mm, and was compressed with a gradually increased pressure until a maximum pressure of 3.5 MPa was reached. The maximum pressure was maintained for one minute, and then the compressed CPC block was removed from the mold. At the 15^th minute following the mixing of the liquid and powders, the compressed CPC block was immersed in a deionized water at 37° C. for 4 day, 8 days, and 16 days. The compressive strength of the specimens of the three different periods of immersion time was measured by using a AGS-500D mechanical tester (Shimadzu Co., Ltd., Kyoto, Japan) after the specimens were dry. The measured dry specimen compressive strength is listed Table 1.

4.32.6

	TABLE 1
	KCl/CPC	Dry compressive strength (MPa)
	ratio by	Immersion time (Day)
	weight	4 day	8 days	16 days
	1	7.0	5.4	6.6
	1.5	3.9	2.7
	2	1.3	2.3

It can seen from Table 1 that the dry compressive strength of the porous CPC blocks decreases as the KCl/CPC ratio by weight increases.

EXAMPLE 2

Effect of KCl Content on Compressive Strength and Porosity of Porous CPC Block

The procedures of EXAMPLE 1 were repeated except that the immersion time was set at four days, and more KCl/CPC ratios by weight were chosen. The results are listed in Table 2.

< td>74.4

TABLE 2
KCl/CPC ratio	Dry compressive
by weight	strength (MPa)	Porosity (vol %)*
1	8.0	66.8
1.25	5.0	69.7
1.5	3.9	72.2
1.75	2.9
2	1.3	76.5
3	0.4	81.9
*Porosity (vol %) was measured by Archimedes' method, and calculated as in ASTM C830.

The results in Table 2 show that the porosity of the porous CPC block becomes greater as the KCl/CPC ratio by weight increases. Morphology of the porous CPC blocks prepared in this example with the KCl/CPC ratios by weight of 1.25, 1.5, 1.75 and 2.0 shows macro and micro-pores, which were observed with SEM.

EXAMPLE 3

Effect of KCl Content and Heat Treatment on Dry Compressive Strength of Porous CPC Block

The procedures of EXAMPLE 1 were repeated except that the immersing time was set at 4 days and the resulting porous CPC block was heat treated. The heat treatment included placing the porous CPC block in an oven at 50° C. for 1 day; and then heating the dried porous CPC block in a furnace at the temperature and for a period of time set in Table 3 with a heating rate of 10° C./min. The compressive strength was measured after cooling of the heated CPC block. The conditions and results are listed in Table 3.

TABLE 3
KCl/CPC ratio	Heat treatment	Dry compressive
by weight	conditions	strength (MPa)
1	No	7
	350° C., 1 hr	8.5
	350° C., 2 hrs	9.6
1.5	No	3.9< /td>
	400° C., 2 hr	4.6

The data in Table 3 show that the heat treatment can enhance the dry compressive strength of the porous CPC block.

EXAMPLE 4

Effect of Molding Pressure and Immersing Liquid on Dry Compressive Strength of Porous CPC Block

The procedures of EXAMPLE 1 were repeated except that the maximum pressure used to compress the paste in the mold was changed from 3.5 MPa to the values listed in Table 4 and the immersion conditions were also changed as indicated in Table 4. Further, the KCl/CPC ratio by weight was set at 2. The conditions and results are listed in Table 4.

TABLE 4
Mold		Dry compressive
pressure	Immersion conditions	strength (MPa)
3.5	MPa	37° C. Deionized water, 4 days	1.3
50	MPa	37� � C. Deionized water, 4 days	4.7
156	MPa	37 ° C. Hanks' solution, 1 day;	5
		37° C. deionized water, 3 days
156	MPa	37° C. Deionized water, 1 day;	4.2
		37° C. Hanks' solution 3 days
156	MPa	37° C. Hanks' solution, 8 days	6
167	MPa	90° C. deionized water, 5 hrs	2.7
167	MPa	90� � C. deionized water, 5 hrs;	3.7
		Hank.s solution 4 days

The data in Table 4 reveal that the dry compressive strength of the porous CPC block increases as the pressure used to compress the paste in the mold increases.

EXAMPLE 5

Porosity and Compressive Strength of Porous CPC Blocks Prepared from Different Pore-Forming Powders

The procedures of EXAMPLE 1 were repeated by using sugar, KI, C₁₇H₃₃COONa and C₁₃H₂₇COOH instead of KCl. The immersion time was 14 days in deionized water. In the cases where the C₁₇H₃₃COONa and C₁₃H₂₇COOH were used, the CPC blocks were further immersed in ethanol for additional four days. The conditions and the results are listed in Table 4.

TABLE 5
Pore-forming powder	Sa)	C.S. (MPa)b)	Porosity (vol %)c)
Sugar	1	4.1	58. 4
KI	2	4.3	62.2
KI	3	1.7	75.5
C17H33COONa	1	8.0	56.0
C13H27COOH	2	5.9	60.1
a)S = Pore-forming powder/CPC by volume.
b)C.S. = dry compressive strength (hereinafter abbreviated as C.S.).
c)Porosity: defined as in Table 2 (hereinafter the same definition will be used unless otherwise indicated).

It can be seen from Table 5 that various powders which are soluble in water can be used in the preparation of a porous CPC block according to the method of the present invention.

EXAMPLE 6

Effect of Immersion Solution and Immersion Temperature on C.S. and Porosity

In this example various immersing liquids at different temperatures were used to prepare porous CPC blocks by repeating the procedures in EXAMPLE 1, wherein the immersion time was set at 14 days, KI was used to replace KCl, and KI/CPC ratio by volume was set at 3. The conditions and results are listed in Table 6.

< tr>

TABLE 6
	Immersion
immersion solution	temperature (° C.)	C.S.	Porosity %
deionized water	37	1.76	75.5
deionized water	25	2.2	—
Ca (OH)2 (0.03 M)	37	2.06	74.7
NaO H (0.03 M)	37	2.14	75.1
CaC l2 (0.03 M)	37	2.03	75.2
NaO H (0.03 M)	25	2.54	73.1

It can been seen from Table 6 that various aqueous solutions which are able to dissolve the pore-forming powder can be used in the preparation of a porous CPC block according to the method of the present invention.

EXAMPLE 7

Effect of Heat Treatment on C.S. and Porosity

The procedures of EXAMPLE 1 were repeated except that the immersion time was set at 14 days, KI was used to replace KCl, and KI/CPC ratio by volume was set at 3. Further the porous CPC block removed from the immersing liquid (deionized water at 37° C.) was dried in an oven and then subjected to a heat treatment at 100–800° C. for a period of 2–10 hours in high temperature furnace with a heating rate of 10° C./min. The conditions and results are listed in Table 7.

	TABLE 7
	Heat treatment condition	C.S. (MPa)
	No	1.7
< td>100° C. - 2 hr	1.7
	200° C. - 2 hr	2.4
	400° C. - 2 hr	2.7
	600° C. - 2 hr	1.5
	800° C. - 2 hr	1.4
	400° C. - 10 hr	2.2
	800° C. - 10 hr	1.4

As shown in Table 7 the optimal conditions for the heat treatment is 400° C. for two hours, thereby the dry compressive strength of the porous CPC block was increased from 1.7 to 2.7 MPa.

EXAMPLE 8

Effect of NaCl Content and Immersion Temperature on C.S. and Porosity

The procedures of EXAMPLE 1 were repeated except that NaCl was used to replace KCl, and NaCl/CPC ratio by weight was set in Table 8. Further the paste was immersed in the immersing liquid (deionized water at 37° C. and 60° C.) for 7 days. The conditions and results are listed in Table 8.

TABLE 8
	Dry compressive strength (MPa)
NaCl/CPC ratio	Immersion temperatue (° C.)
by weight	37	60
0	75.5	58.2
0.25	28.8	27.9
0. 5	11.2	10.4
0.75	5. 8	8.3
1	6.7	6.1
1.25	—	5.2
	Porosity (%)
NaCl/CPC ratio	Immersion temperatue (° C.)
by weight	37	60
0	33.3	37.3
0.25	46.1	41.9
0. 5	49.4	54.3
0.75	56 .1	59.4
1	—	64.2< /td>
1.25	63.9	67.9

EXAMPLE 9

Effect of NaCl Content and Heat Treatment on C.S.

The procedures of EXAMPLE 1 were repeated except that NaCl was used to replace KCl, the paste was immersed in the immersing liquid (deionized water at 37° C.) for 7 days, and NaCl/CPC ratio by weight was set in Table 9. Further the resulting porous CPC block was heat treated. The heat treatment included heating the porous CPC block in a furnance at the temperature set in Table 9 for 1 hr with a heating rate of 10° C./min. The compressive strength was measured after cooling of the heated CPC block. The conditions and results are listed in Table 9.

TABLE 9
	Dry compressive strength (MPa)
Heat treatment	NaCl/CPC ratio by weight
temperatue (° C.)	0.25	0.5
Without heat treatment	28.8	11.2
50	38.8	16.1
100	36.8	21.0
200	46.1	29.5
350	54.5	30.0
400	39.4	29.5
450	3 6.6	18.3

In the other preferred embodiments of the present invention Na₂CO₃ was used as the pore-forming powder in the preparation of the porous CPC blocks, which had the dry compressive strength and the porosity comparable to those disclosed in Examples 1–9.

Although the present invention has been described with reference to specific details of certain embodiments thereof, it is not intended that such details should be regarded as limitations upon the scope of the invention except as and to the extent that they are included in the accompanying claims. Many modifications and variations are possible in light of the above disclosure.